advertisement
Landry TA 3
Showing records 1 to 3 | Display all abstracts from Landry TA16879 Effects of travoprost on aqueous humor dynamics in patients with elevated intraocular pressure
Toris CB; Zhan G; Fan S; Dickerson JE; Landry TA; Bergamini MVB; Camras CB
Journal of Glaucoma 2007; 16: 189-195
16897 Travoprost 0.004% with and without benzalkonium chloride: a comparison of safety and efficacy
Lewis RA; Katz GJ; Weiss MJ; Landry TA; Dickerson JE; James JE; Hua SY; Sullivan EK; Montgomery DB; Wells DT
Journal of Glaucoma 2007; 16: 98-103
17134 Patients' and physicians' perceptions of the travoprost dosing aid: An open-label, multicenter study of adherence with prostaglandin analogue therapy for open-angle glaucoma or ocular hypertension
Flowers B; Wand M; Piltz-Seymour J; Berke SJ; Day D; Teague J; Smoot TM; Landry TA; Bergamini MVW; Mallick S
Clinical Therapeutics 2006; 28: 1803-1811